Home » Business » Manufacturing
Roche eyes firm to boost position
SWISS pharmaceutical company Roche Group yesterday said it is buying California-based medical scanning company BioImagene Inc for US$100 million to strengthen its position in the field of tissue-based cancer diagnostics and research.
"The increasing complexity of new tests and technologies creates tremendous need for more sophisticated tools for tissue analysis and diagnosis," the head of Roche's diagnostics division, Daniel O'Day, said in a statement.
Privately-held BioImagene, based in Sunnyvale, specializes in producing high-resolution pictures from microscope slides and also provides image archiving and retrieval products for pathologists.
Analysts at Helvea said the acquisition would complement and strengthen Roche's existing diagnostics portfolio, particularly at its subsidiary Ventana Medical Systems Inc.
Switzerland-based Roche said it expects to complete the purchase of BioImagene in the coming weeks.
"The increasing complexity of new tests and technologies creates tremendous need for more sophisticated tools for tissue analysis and diagnosis," the head of Roche's diagnostics division, Daniel O'Day, said in a statement.
Privately-held BioImagene, based in Sunnyvale, specializes in producing high-resolution pictures from microscope slides and also provides image archiving and retrieval products for pathologists.
Analysts at Helvea said the acquisition would complement and strengthen Roche's existing diagnostics portfolio, particularly at its subsidiary Ventana Medical Systems Inc.
Switzerland-based Roche said it expects to complete the purchase of BioImagene in the coming weeks.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证:沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证:31120180004
- |
- 网络视听许可证:0909346
- |
- 广播电视节目制作许可证:沪字第354号
- |
- 增值电信业务经营许可证:沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.